nifedipine controlled release (teva)
teva pharma (new zealand) limited - nifedipine 60mg; ; - modified release tablet - 60 mg - active: nifedipine 60mg excipient: carbomer 934p colloidal silicon dioxide hypromellose iron oxide red lactose monohydrate macrogol 4000 magnesium stearate methacrylic acid copolymer povidone purified talc titanium dioxide - treatment of mild to moderate hypertension.
nifedipine tablet extended release
teva pharmaceuticals usa - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 60 mg
nifedipine tablet film coated extended release
remedyrepack inc. - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 90 mg
nifedipine tablet film coated extended release
avera mckennan hospital - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 30 mg
nifedipine extended release tablet
lake erie medical dba quality care products llc - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 90 mg
nifedipine tablet extended release
mckesson packaging servives a business unit of mckesson corporation - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 30 mg
nifedipine extended release tablet
avera mckennan hospital - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 30 mg
nifedipine extended release tablet
american health packaging - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 30 mg
nifedipine tablet extended release
mckesson packaging services business unit of mckesson corporation - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 30 mg
nifedipine extended release- nifedipine tablet, extended release
lake erie medical dba quality care products llc - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine extended-release tablets, usp are indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. concomitant administration with strong p450 inducers, such as rifampin, are contraindicated since the efficacy of nifedipine tablets could be significantly reduced. (see precautions , drug interactions . ) nifedipine must not be used in cases of cardiogenic shock. nifedipine is contraindicated in patients with a known hypersensitivity to any component of the tablet.